Status:
UNKNOWN
Accuracy, Feasibility and Acceptance of CGM Lupus
Lead Sponsor:
RenJi Hospital
Conditions:
Systemic Lupus Erythematosus
Critical Illness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective monocenter, non-randomised, open-lable single-group intervention diagnostic trial on the accuracy, reliability and feasibility of the continuous glucose monitoring system in crit...
Eligibility Criteria
Inclusion
- Systemic lupus erythematosus (SLE), as defined by meeting at least 4 of 11 classification criteria of American College of Rheumatology for the classification of systemic lupus erythematosus, either sequentially or coincidentally. The 4 criteria doesn't need to be present at the time of study enrollment;
- critically SLE patients
- informed consent by the patients or legal proxy
Exclusion
- age \< 18
- no informed consent by the patients or legal proxy
- pregnancy
- infaust prognosis
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03296995
Start Date
July 1 2017
End Date
October 1 2019
Last Update
September 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shuang Ye, MD
Shanghai, Shanghai Municipality, China